Skip to main content
OpenTrials

Clinical trial condition

Lymphatic Diseases

Explore clinical trials studying Lymphatic Diseases. Study availability and eligibility vary by location and protocol.

8,984 public trials 1,830 recruiting studies
Refine in advanced search Browse all conditions

Lymphatic Diseases trial results

Completed

Study of MDX-1203 in Subjects With Advanced/Recurrent Clear Cell Renal Cell Carcinoma (ccRCC) or Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (B-NHL)

NCT00944905

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +22 more
Locations
  • Yale University School of Medicine New Haven, Connecticut, United States
  • Emory University Winship Cancer Center Atlanta, Georgia, United States
  • The University of Chicago Chicago, Illinois, United States
  • University of Maryland Greenebaum Cancer Center Baltimore, Maryland, United States
View Trial Details
Completed

Study of the Safety and Tolerability of PCI-32765 in Patients With Recurrent B Cell Lymphoma

NCT00849654

Conditions
B-cell Leukemia, B-cell Lymphoma, Blood Protein Disorders, +31 more
Locations
  • Stanford University School of Medicine Palo Alto, California, United States
  • University of Chicago Chicago, Illinois, United States
  • National Cancer Institute Bethesda, Maryland, United States
  • New York Prebyterian Hospital Cornell Medical Center New York, United States
View Trial Details
Completed

SWOG-8819 Collecting, Analyzing, and Storing Tissue Samples From Patients With Non-Hodgkin's Lymphoma

NCT00900484

Conditions
Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +21 more
Locations
  • Alaska Regional Hospital Cancer Center Anchorage, Alaska, United States
  • Alta Bates Summit Comprehensive Cancer Center Berkeley, California, United States
  • Peninsula Medical Center Burlingame, California, United States
  • North Bay Cancer Center Fairfield, California, United States
View all 191 locations
View Trial Details
Completed

SWOG-8947 Collecting and Storing Blood Samples From Patients With Previously Untreated Non-Hodgkin Lymphoma

NCT01000558

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
Locations
  • Providence Cancer Center at Providence Hospital Mobile, Alabama, United States
  • Alaska Regional Hospital Cancer Center Anchorage, Alaska, United States
  • Hembree Mercy Cancer Center at St. Edward Mercy Medical Center Fort Smith, Arkansas, United States
  • Alta Bates Summit Comprehensive Cancer Center Berkeley, California, United States
View all 203 locations
View Trial Details
Completed

SWOG-9245 Collecting and Storing Tissue Samples From Patients With Relapsed or Recurrent Non-Hodgkin Lymphoma After Treatment on a Southwest Oncology Group Clinical Trial

NCT00898872

Conditions
Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +42 more
Locations
  • Alaska Regional Hospital Cancer Center Anchorage, Alaska, United States
  • Piedmont Hospital Atlanta, Georgia, United States
  • Northside Hospital Cancer Center Atlanta, Georgia, United States
  • Saint Joseph's Hospital of Atlanta Atlanta, Georgia, United States
View all 82 locations
View Trial Details
Completed

Bortezomib in Treating Patients With Waldenstrom's Macroglobulinemia

NCT00045695

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations
  • Hinsdale Hematology Oncology Associates Hinsdale, Illinois, United States
  • Abramson Cancer Center at the University of Pennsylvania Philadelphia, Pennsylvania, United States
  • Tom Baker Cancer Centre - Calgary Calgary, Alberta, Canada
  • Cross Cancer Institute Edmonton, Alberta, Canada
View Trial Details

Related conditions